Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea · Delayed Price · Currency is KRW 6,080.00
-60.00 (-0.98%)
At close: Oct 21, 2026
Biodyne Market Cap
Biodyne has a market cap or net worth of 179.22 billion as of October 21, 2026. It is the 23,237th most valuable company in the world and the 907th biggest in South Korea. Its market cap has decreased by 57.30% in one year.
Market Cap
179.22B
Enterprise Value
164.47B
Revenue
5.77B
Global Rank
Country Rank
#907 South Korea
PE Ratio
148.69
ChartMarket Cap Chart
Since March 17, 2021, Biodyne's market cap has decreased from 252.12B to 179.22B, a decrease of -28.91%. That is a compound annual growth rate of -5.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 179.22B | -55.40% |
| Dec 30, 2025 | 401.82B | -16.15% |
| Dec 30, 2024 | 479.20B | 19.24% |
| Dec 28, 2023 | 401.88B | 185.76% |
| Dec 29, 2022 | 140.63B | -31.74% |
| Dec 30, 2021 | 206.02B | -18.28% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Livsmed | 1.10T |
| Curiox Biosystems | 928.98B |
| BIOBIJOU | 180.29B |
| M.I.TECH Co.,Ltd | 151.31B |
| Synergy Innovation | 128.81B |
| Celemics | 109.69B |
| RecensMedical | 72.60B |
| Corentec | 69.99B |